Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Kronos Bio Inc (KRON)

Kronos Bio Inc (KRON)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Help
Go To:
Kronos Bio Enters into Agreement to Be Acquired by Concentra Biosciences for $0.57 in Cash per Share Plus a Contingent Value Right GlobeNewswire - Thu May 1, 2025

KRON : 0.8800 (+1.49%)
Kronos Bio Reports Fourth Quarter and Full Year 2024 Financial Results GlobeNewswire - Tue Mar 18, 2025

KRON : 0.8800 (+1.49%)
Kronos Bio Announces Leadership Change with Deborah Knobelman Appointed as President and Interim CEO Quiver Quantitative, Inc. - Wed Nov 27, 2024

Kronos Bio appoints Deborah Knobelman as President and Interim CEO, succeeding Norbert Bischofberger amidst significant workforce reduction.Quiver AI SummaryKronos Bio, Inc. announced that Dr. Deborah...

KRON : 0.8800 (+1.49%)
Kronos Bio Stock Jumps After Deep Workforce Cuts And CEO Shuffle: Retail Aligns With Shake-Up Stocktwits - Wed Nov 27, 2024

The company said this move is part of a broader strategy to implement cost-cutting measures.

IWC : 168.25 (-1.00%)
KRON : 0.8800 (+1.49%)
VXF : 218.10 (-0.62%)
VTI : 341.47 (-0.10%)
Kronos Bio Announces CEO Transition and Reduction in Force GlobeNewswire - Wed Nov 27, 2024

KRON : 0.8800 (+1.49%)
Kronos Bio Highlights Preclinical Data that Show p300 KAT Inhibitors Reduce Inflammation in an Oral Presentation at ACR Convergence 2024 GlobeNewswire - Thu Nov 14, 2024

KRON : 0.8800 (+1.49%)
Kronos Bio Reports Third Quarter 2024 Financial Results and Corporate Update Including Plan to Evaluate Strategic Alternatives GlobeNewswire - Wed Nov 13, 2024

KRON : 0.8800 (+1.49%)
Kronos Bio to Present Data at the ASH Annual Meeting from p300 KAT Inhibition Program in Multiple Myeloma GlobeNewswire - Tue Nov 5, 2024

KRON : 0.8800 (+1.49%)
Kronos Bio Data Presentation at EORTC-NCI-AACR Symposium Highlights the Importance of p300 KAT Inhibition in HPV-Driven Tumors GlobeNewswire - Wed Oct 23, 2024

KRON : 0.8800 (+1.49%)
Kronos Bio to Present Data at the EORTC-NCI-AACR Symposium that Supports p300 KAT Inhibition in HPV-Driven Tumors GlobeNewswire - Wed Oct 9, 2024

KRON : 0.8800 (+1.49%)

Barchart Exclusives

This Outperforming Dividend Stock Increased Its 2026 Payout by 20%: Should You Buy? Barchart - Wed Feb 11, 6:30PM CST
GM increased its 2026 dividend by 20%, and while its dividend yield is below Ford's, it looks like a better buy compared to the Blue Oval. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot